Other Relevant Articles - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Volume brings value
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography and Intervention
Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention

Guideline

January 2019

JOURNAL：J Am Coll Cardiol.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

CT January, LS Wann, H Calkins et al.

10781

Keywords: Anticoagulation Management; Arrhythmias and Clinical EP; Heart Failure and Cardiomyopathies; Invasive Cardiovascular Angiography and Intervention; Prevention; Valvular Heart Disease; Anticoagulation Management and Atrial Fibrillation; Implantable Devices; SCD/Ventricular Arrhythmias; Atrial Fibrillation/Supraventricular Arrhythmias; Novel Agents; Acute Heart Failure; Interventions and Structural Heart Disease

FULL TEXT PDF